While obesity (elevated adiposity) is a well-established risk factor for the development of IR, there is also evidence suggesting that IR may promote abdominal fat accumulation, creating a vicious cycle that perpetuates both conditions through cell-autonomous mechanisms or by inducing inflammation and the subsequent production of inflammatory cytokines by macrophages, which impair insulin action [22,23]. The gene discussed is INS; the disease is Obesity.